-
Basi G, Schmid E, Maundrell K. TATA box mutations in the Schizosaccharomyces pombe nmt1 promoter affect transcription efficiency but not the transcription start point or thiamine repressibility[J]. Gene, 1993, 123(): 131-136. doi: 10.1016/0378-1119(93)90552-E
-
Chang D D, Sharp P A. Regulation by HIV Rev depends upon recognition of splice sites[J]. Cell, 1989, 59(): 789-795. doi: 10.1016/0092-8674(89)90602-8
-
Chatterji U, Grant C K, Elder J H. Feline immunodeficiency virus Vif localizes to the nucleus[J]. J Virol, 2000, 74(): 2533-2540. doi: 10.1128/JVI.74.6.2533-2540.2000
-
Conticello S G, Harris R S, Neuberger M S. The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G[J]. Curr Biol, 2003, 13(): 2009-2013. doi: 10.1016/j.cub.2003.10.034
-
Dutko J A, Schafer A, Kenny A E. Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases[J]. Curr Biol, 2005, 15(): 661-666. doi: 10.1016/j.cub.2005.02.051
-
Esnault C, Heidmann O, Delebecque F. APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses[J]. Nature, 2005, 433(): 430-433. doi: 10.1038/nature03238
-
Feng F, Davis A, Lake J A. Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif[J]. J Virol, 2004, 78(): 10574-10581. doi: 10.1128/JVI.78.19.10574-10581.2004
-
Gabuzda D H, Lawrence K, Langhoff E. Role of Vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes[J]. J Virol, 1992, 66(): 6489-6495.
-
Goff S P. Retrovirus restriction factors[J]. Mol Cell, 2004, 16(): 849-859. doi: 10.1016/j.molcel.2004.12.001
-
Goff S P. Death by deamination: A novel host restriction system for HIV-1[J]. Cell, 2003, 114(): 281-283. doi: 10.1016/S0092-8674(03)00602-0
-
Goncalves J, Jallepalli P, Gabuzda D H. Subcellular localization of the Vif protein of human immunodeficiency virus type 1[J]. J Virol, 1994, 68(): 704-712.
-
Harris R S, Liddament M T. Retroviral restriction by APOBEC proteins[J]. Nat Rev Immunol, 2004, 4(): 868-877. doi: 10.1038/nri1489
-
Hollams E M, Giles K M, Thomson A M. mRNA stability and the control of gene expression: implications for human disease[J]. Neurochem Res, 2002, 27(): 957-980. doi: 10.1023/A:1020992418511
-
Kao S, Khan M A, Miyagi E. The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity[J]. J Virol, 2003, 77(): 11398-11407. doi: 10.1128/JVI.77.21.11398-11407.2003
-
Karczewski M K, Strebel K. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein[J]. J Virol, 1996, 70(): 494-507.
-
Kjems J, Askjaer P. Rev protein and its cellular partners[J]. Adv Pharmacol, 2000, 48(): 251-298. doi: 10.1016/S1054-3589(00)48009-9
-
Liu B, Yu X, Luo K. Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G[J]. J Virol, 2004, 78(): 2072-2081. doi: 10.1128/JVI.78.4.2072-2081.2004
-
Luo K, Xiao Z, Ehrlich E. Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G[J]. Proc Natl Acad Sci USA, 2005, 102(): 11444-11449. doi: 10.1073/pnas.0502440102
-
Madani N, Millette R, Platt E J. Implication of the lymphocyte-specific nuclear body protein Sp140 in an innate response to human immunodeficiency virus type 1[J]. J Virol, 2002, 76(): 11133-11138. doi: 10.1128/JVI.76.21.11133-11138.2002
-
Maldarelli F, Martin M A, Strebel K. Identification of posttranscriptionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation[J]. J Virol, 1991, 65(): 5732-5743.
-
Marin M, Rose K M, Kozak S L. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation[J]. Nat Med, 2003, 9(): 1398-1403. doi: 10.1038/nm946
-
Maundrell K. nmt1 of fission yeast. A highly transcribed gene completely repressed by thiamine[J]. J Biol Chem, 1990, 265(): 10857-10864.
-
Maundrell K. Thiamine-repressible expression vectors pREP and pRIP for fission yeast[J]. Gene, 1993, 123(): 127-130. doi: 10.1016/0378-1119(93)90551-D
-
Mehle A, Goncalves J, Santa-Marta M. Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APO-BEC3G degradation[J]. Genes Dev, 2004, 18(): 2861-2866. doi: 10.1101/gad.1249904
-
Mehle A, Strack B, Ancuta P. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway[J]. J Biol Chem, 2004, 279(): 7792-7798. doi: 10.1074/jbc.M313093200
-
Wichroski M J, Ichiyama K, Rana T M.. Analysis of HIV-1 Viral Infectivity Factor-mediated Proteasome-dependent Depletion of APOBEC3G[J]. J Biol Chem, 2005, 280(): 8387-8396. doi: 10.1074/jbc.M408048200
-
Moreno, Hayles, Nurse, P. Molecular Genetic Analysis of Fission Yeast Schizosaccharomyces pombe[J]. Methods Enzymol, 1991, 194(): 795-823. doi: 10.1016/0076-6879(91)94059-L
-
Santa-Marta M, da Silva F A, Fonseca A M. HIV-1 Vif can directly inhibit apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G-mediated cytidine deamination by using a single amino acid inter-action and without protein degradation[J]. J Biol Chem, 2005, 280(): 8765-8775. doi: 10.1074/jbc.M409309200
-
Schneider R, Campbell M, Nasioulas G. Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation[J]. J Virol, 1997, 71(): 4892-4903.
-
Schwartz S, Felber B K, Pavlakis G N. Distinct RNA sequences in the gag region of human immunode-ficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein[J]. J Virol, 1992, 66(): 150-159.
-
Simon J H, Carpenter E A, Fouchier R A. Vif and the p55(Gag) polyprotein of human immunode-ficiency virus type 1 are present in colocalizing membrane-free cytoplasmic complexes[J]. J Virol, 1999, 73(): 2667-2674.
-
Sova P, Volsky D J. Efficiency of viral DNA synthesis during infection of permissive and nonper-missive cells with Vif-negative human immunodeficiency virus type 1[J]. J Virol, 1993, 67(): 6322-6326.
-
Sreekrishna K, Brankamp R G, Kropp K E. Subramaniam and L.A. Birkenberger, Strategies for optimal synthesis and secretion of heterologous proteins in the methylotrophic yeast Pichia pastoris[J]. Gene, 1997, 190(): 55-62. doi: 10.1016/S0378-1119(96)00672-5
-
Stopak K, de Noronha C, Yonemoto W, et al. 2003. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol Cell, 12: 591-601.
-
Turelli P, Mangeat B, Jost S. Inhibition of hepatitis B virus replication by APOBEC3G[J]. Science, 2004, 303(): 1829-. doi: 10.1126/science.1092066
-
Wichroski M J, Ichiyama K, Rana T M. Analysis of HIV-1 viral infectivity factor-mediated proteasome-dependent depletion of APOBEC3G: Correlating function and subcellular localization[J]. J Biol Chem, 2005, 280(): 8387-8396. doi: 10.1074/jbc.M408048200
-
Wiegand H L, Doehle B P, Bogerd H P. A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins[J]. EMBO J, 2004, 23(): 2451-2458. doi: 10.1038/sj.emboj.7600246
-
Yu X, Yu Y, Liu B. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex[J]. Science, 2003, 302(): 1056-1060. doi: 10.1126/science.1089591
-
Yu Y, Xiao Z, Ehrlich E S. Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines[J]. Genes Dev, 2004, 18(): 2867-2872. doi: 10.1101/gad.1250204
-
Zhao Y, Cao J, O'Gorman M R. Effect of human immunodeficiency virus type 1 protein R (vpr) gene expression on basic cellular function of fission yeast Schizosaccharomyces pombe[J]. J Virol, 1996, 70(): 5821-5826.
-
Zhao Y, Elder R T, Chen M. Fission yeast expression vectors adapted for positive identification of gene insertion and green fluorescent protein fusion[J]. Biotechniques, 1998, 25(): 438-440, 442, 444.
-
Zheng Y H, Irwin D, Kurosu T. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication[J]. J Virol, 2004, 78(): 6073-6076. doi: 10.1128/JVI.78.11.6073-6076.2004